News
PVCT
0.144
+1.56%
0.002
Weekly Report: what happened at PVCT last week (0219-0223)?
Weekly Report · 1d ago
Provectus Pharmaceuticals Hosts Investor Conference Call
TipRanks · 4d ago
Notable earnings before Thursday's open
Major earnings expected before the bell on Thursday include Dominion Energy (D) and Newmont (NEM) Other major earnings slated for release before Thursday's open include: Old Dominion Energy, Iron Mountain, Newmont and Nikola. The company will report its fourth quarter and full year earnings before the open.
Seeking Alpha · 5d ago
Weekly Report: what happened at PVCT last week (0212-0216)?
Weekly Report · 02/19 10:23
Provectus Pharmaceuticals Announces Upcoming Conference Call
TipRanks · 02/15 13:23
Weekly Report: what happened at PVCT last week (0205-0209)?
Weekly Report · 02/12 10:16
Weekly Report: what happened at PVCT last week (0129-0202)?
Weekly Report · 02/05 10:21
Weekly Report: what happened at PVCT last week (0122-0126)?
Weekly Report · 01/29 10:15
Weekly Report: what happened at PVCT last week (0115-0119)?
Weekly Report · 01/22 10:17
Weekly Report: what happened at PVCT last week (0108-0112)?
Weekly Report · 01/15 10:15
Weekly Report: what happened at PVCT last week (0101-0105)?
Weekly Report · 01/08 10:17
Weekly Report: what happened at PVCT last week (1225-1229)?
Weekly Report · 01/01 10:14
Weekly Report: what happened at PVCT last week (1218-1222)?
Weekly Report · 12/25/2023 10:21
Weekly Report: what happened at PVCT last week (1211-1215)?
Weekly Report · 12/18/2023 10:24
Weekly Report: what happened at PVCT last week (1204-1208)?
Weekly Report · 12/11/2023 10:22
Weekly Report: what happened at PVCT last week (1127-1201)?
Weekly Report · 12/04/2023 10:21
Weekly Report: what happened at PVCT last week (1120-1124)?
Weekly Report · 11/27/2023 10:17
Weekly Report: what happened at PVCT last week (1113-1117)?
Weekly Report · 11/20/2023 10:16
Weekly Report: what happened at PVCT last week (1106-1110)?
Weekly Report · 11/13/2023 10:12
Weekly Report: what happened at PVCT last week (1030-1103)?
Weekly Report · 11/06/2023 10:15
More
Webull provides a variety of real-time PVCT stock news. You can receive the latest news about Provectus Biopha through multiple platforms. This information may help you make smarter investment decisions.
About PVCT
Provectus Biopharmaceuticals, Inc. is a development-stage biopharmaceutical company. The Company is engaged in developing pharmaceuticals for oncology and dermatology indications. The Company is focused on developing its prescription drug candidates, PV-10 and PH-10. It is developing PV-10 for treatment of several life threatening cancers, including metastatic melanoma, liver cancer and breast cancer. It is developing PH-10 to provide minimally invasive treatment of chronic severe skin afflictions, such as psoriasis and atopic dermatitis, a type of eczema. In addition to clinical trials, patients enrolled in the expanded access or compassionate use program for PV-10 are also receiving PV-10 treatments for cutaneous and subcutaneous cancer indications. The Company also focuses on over-the-counter (OTC) products and various other non-core technologies. PV-10 is a sterile injectable form of rose bengal disodium (Rose Bengal), for direct injection into tumors.